BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update
Go back to BridgeBio Pharma Reports Second Quarter 2024 Financial Results and Business Update| (NASDAQ: BBIO) | Delayed: 75.51 +0.67 (0.90%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $74.84 | 52 Week High | $ | |||
| Open | $73.60 | 52 Week Low | $ | |||
| Day High | $76.34 | P/E | N/A | |||
| Day Low | $73.26 | EPS | $ | |||
| Volume | 321,404 | |||||

